The "Program to Industrialize an Innovative Middle Molecule Drug Discovery Flow through Fusion of Computational Drug Design and Chemical Synthesis Technology," which were supported from MEXT with "Program for Building Regional Innovation Ecosystems" has finished on March 31st, 2022. The contents for the program are archived here.
The Middle Molecule IT-based Drug Discovery Laboratory (MIDL) is still running as one of the "Innovation Research Initiatives" at Tokyo Institute of Technology. New information is uploaded on
the new website.
